These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 9269124

  • 1. Polycystic ovarian syndrome and pregnancy.
    Paternoster D, Vanin M.
    Minerva Ginecol; 1997 Jun; 49(6):293-7. PubMed ID: 9269124
    [Abstract] [Full Text] [Related]

  • 2. Oocytes collected 60 hours after human chorionic gonadotropin administration from patients with polycystic ovary syndrome who underwent limited ovarian stimulation resulted in clinical pregnancies and the delivery of a healthy baby.
    El-Sheikh MM, Sehly N, Al Mesiry W, Fouad S.
    Fertil Steril; 2005 Dec; 84(6):1758-61. PubMed ID: 16359985
    [Abstract] [Full Text] [Related]

  • 3. Hypothesis: Persistently elevated hCG causes gestational ovarian overstimulation associated with prolonged postpartum hyperandrogenism in mothers of aromatase-deficient babies.
    Riedl S, Springer A, Häusler G, Price G, Richter-Unruh A, Stener-Victorin E, Wudy SA.
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3115-20. PubMed ID: 23824416
    [Abstract] [Full Text] [Related]

  • 4. Maternal hyperandrogenism beginning from early pregnancy and progressing until delivery does not produce virilization of a female newborn.
    Bertalan R, Csabay L, Blazovics A, Rigo J, Varga I, Halasz Z, Toldy E, Boyle B, Racz K.
    Gynecol Endocrinol; 2007 Oct; 23(10):581-3. PubMed ID: 17852424
    [Abstract] [Full Text] [Related]

  • 5. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
    Ge HS, Huang XF, Zhang W, Zhao JZ, Lin JJ, Zhou W.
    Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
    [Abstract] [Full Text] [Related]

  • 6. The relationship between perinatal outcome of singleton pregnancies and isolated highly elevated levels of maternal serum human chorionic gonadotropin at mid-gestation.
    Tavor O, Shohat M, Lipitz S.
    Isr Med Assoc J; 2007 Jul; 9(7):509-12. PubMed ID: 17710780
    [Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
    Palomba S, Falbo A, Orio F, Manguso F, Russo T, Tolino A, Annamaria C, Dale B, Zullo F.
    Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?
    Nawaz FH, Khalid R, Naru T, Rizvi J.
    J Obstet Gynaecol Res; 2008 Oct; 34(5):832-7. PubMed ID: 18834342
    [Abstract] [Full Text] [Related]

  • 10. Abnormal human chorionic gonadotropin levels and normal pregnancy outcomes in the ovarian hyperstimulation syndrome.
    Samuel MJ, Grosskinsky CM.
    J Reprod Med; 2004 Jan; 49(1):8-12. PubMed ID: 14976788
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
    Moran C, Renteria JL, Moran S, Herrera J, Gonzalez S, Bermudez JA.
    Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
    [Abstract] [Full Text] [Related]

  • 16. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, Brooks B, Mimoni T, Eldar-Geva T.
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [Abstract] [Full Text] [Related]

  • 17. Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles.
    Seow KM, Juan CC, Hsu YP, Ho LT, Wang YY, Hwang JL.
    Hum Reprod; 2005 Jan; 20(1):117-21. PubMed ID: 15513972
    [Abstract] [Full Text] [Related]

  • 18. [Virilizing luteoma of pregnancy. Relation to polycystic ovaries].
    Guilmot JL, Avignon JP, Lecomte P, Boscq G, Billard JJ, Delsol M.
    Sem Hop; 1983 Dec 01; 59(44):3053-7. PubMed ID: 6320393
    [Abstract] [Full Text] [Related]

  • 19. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome.
    Schoyer KD, Liu HC, Witkin S, Rosenwaks Z, Spandorfer SD.
    Fertil Steril; 2007 Jul 01; 88(1):139-44. PubMed ID: 17320874
    [Abstract] [Full Text] [Related]

  • 20. Nonimmunologic fetal hydrops associated with hyperreactio luteinalis.
    Hatjis CG.
    Obstet Gynecol; 1985 Mar 01; 65(3 Suppl):11S-13S. PubMed ID: 3883269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.